MAPS Sends Expert Delegation to United Nations Commission on Narcotic Drugs
Vienna, Austria; March 9, 2026 —The Multidisciplinary Association for Psychedelic Studies (MAPS) will send senior academics, advocates, Veterans, and policy experts to the 69th session of the United Nations Commission on Narcotic Drugs (CND) in Vienna, Austria, held March 9-13, 2026. The MAPS delegation brings together experts and leaders from the United States, Europe, Australia,… Continue reading MAPS Sends Expert Delegation to United Nations Commission on Narcotic Drugs
External link. We are not responsible for the content.
Read more ↗More From MAPS
In a Defining Election Year, MAPS Releases Policy Guidebook to Shape the Future of Psychedelic Reform
Washington, DC; February 4, 2026 — With the United States in a pivotal election year, the Multidisciplinary Associati...
MAPS and Columbia University Partner on First-of-its-Kind Study of MDMA-Assisted Couples Therapy
February 2, 2026 — The Multidisciplinary Association for Psychedelic Studies (MAPS) announces a formal research partn...
Green, Volat Transition from the MAPS Board of Directors to Committee Members
January 14, 2026 — In October 2025, Joe Green and Miriam Volat resigned their positions as members of the MAPS Board ...
Latest News
Colorado’s Ibogaine Bill Could Be a Landmark — If It Respects the Plant’s Roots
HB26-1325 would create a state-supported ibogaine research program to study addiction and PTSD treatment, including f...
Will the FDA ever fast-track psychedelic drugs? 5 Questions with drug regulation expert Daniel Eisenkraft Klein
Eisenkraft Klein discusses the FDA’s new accelerated drug review program.
Joe Moore Psychedelics Today on Leadership, Integration, and the Psychedelic Landscape
Jen Davenport joins Psychedelics Today to interview the CEO and co-founder Joe Moore about the growth of Psychedelics...
AtaiBeckley Seeks Partner for BPL-003 as Pharma Interest Builds After AbbVie-Gilgamesh Deal
AtaiBeckley is in structured discussions with pharma companies and royalty investors about a potential partnership fo...
Psilocybin Isn’t Legal Yet. So, Why Are States Writing Laws for It?
PLUS ketamine spoons, sleep tripping, and psilocybin vs. anti-depressants. [...] Read More... The post Psilocybin Isn...
The Therapeutic Potential of Psychedelics in the Treatment of Substance Use Disorders
Substance use disorders (SUDs) remain among the most persistent global public health challenges. Despite decades of p...